STOCK TITAN

Albemarle Corp Financials

ALB
Source SEC Filings (10-K/10-Q) Updated Feb 11, 2026 Currency USD FYE February

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 49 / 100
Financial Profile 49/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability
36

Albemarle Corp has an operating margin of 7.1%, meaning the company retains $7 of operating profit per $100 of revenue. This results in a moderate score of 36/100, indicating healthy but not exceptional operating efficiency. This is up from -33.0% the prior year.

Growth
0

Albemarle Corp's revenue declined 99.9% year-over-year, from $5.4B to $5.1M. This contraction results in a growth score of 0/100.

Leverage
99

Albemarle Corp carries a low D/E ratio of 0.33, meaning only $0.33 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 99/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
69

With a current ratio of 2.23, Albemarle Corp holds $2.23 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 69/100.

Cash Flow
67

Albemarle Corp converts 13.5% of revenue into free cash flow ($692K). This strong cash generation earns a score of 67/100.

Returns
21

Albemarle Corp generates a 5.4% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 21/100.

Altman Z-Score Safe
1720.37

Albemarle Corp scores 1720.37, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($19.6B) relative to total liabilities ($6.8M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral
6/9

Albemarle Corp passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
2.51x

For every $1 of reported earnings, Albemarle Corp generates $2.51 in operating cash flow ($1.3M OCF vs $511K net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
333712.7x

Albemarle Corp earns $333712.7 in operating income for every $1 of interest expense ($367K vs $1). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

This page shows Albemarle Corp (ALB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue
$5.1M
YoY-99.9%
5Y CAGR-72.3%
10Y CAGR-46.8%

Albemarle Corp generated $5.1M in revenue in fiscal year 2025. This represents a decrease of 99.9% from the prior year.

EBITDA
$1.0M
YoY+100.1%
5Y CAGR-73.2%
10Y CAGR-47.2%

Albemarle Corp's EBITDA was $1.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 100.1% from the prior year.

Free Cash Flow
$692K
YoY+100.1%
10Y CAGR-40.9%

Albemarle Corp generated $692K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 100.1% from the prior year.

Net Income
$511K
YoY+100.0%
5Y CAGR-73.3%
10Y CAGR-47.7%

Albemarle Corp reported $511K in net income in fiscal year 2025. This represents an increase of 100.0% from the prior year.

EPS (Diluted)
$5.76
YoY+151.4%
5Y CAGR+10.4%
10Y CAGR+6.7%

Albemarle Corp earned $5.76 per diluted share (EPS) in fiscal year 2025. This represents an increase of 151.4% from the prior year.

Cash & Debt
$1.6B
YoY+35.7%
5Y CAGR+16.7%
10Y CAGR+22.4%

Albemarle Corp held $1.6B in cash against $3.1M in long-term debt as of fiscal year 2025.

Dividends Per Share
$1.60
YoY-0.6%
5Y CAGR+0.8%
10Y CAGR+3.3%

Albemarle Corp paid $1.60 per share in dividends in fiscal year 2025. This represents a decrease of 0.6% from the prior year.

Shares Outstanding
118M
YoY+0.2%
5Y CAGR+0.2%
10Y CAGR+0.5%

Albemarle Corp had 118M shares outstanding in fiscal year 2025. This represents an increase of 0.2% from the prior year.

Gross Margin
13.0%
YoY+11.8pp
5Y CAGR-18.8pp
10Y CAGR-17.4pp

Albemarle Corp's gross margin was 13.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 11.8 percentage points from the prior year.

Operating Margin
7.1%
YoY+40.2pp
5Y CAGR-9.0pp
10Y CAGR-5.1pp

Albemarle Corp's operating margin was 7.1% in fiscal year 2025, reflecting core business profitability. This is up 40.2 percentage points from the prior year.

Net Margin
9.9%
YoY+31.9pp
5Y CAGR-2.1pp
10Y CAGR-1.9pp

Albemarle Corp's net profit margin was 9.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 31.9 percentage points from the prior year.

Return on Equity
5.4%
5Y CAGR-3.4pp
10Y CAGR-4.9pp

Albemarle Corp's ROE was 5.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

R&D Spending
$51K
YoY-99.9%
5Y CAGR-75.6%
10Y CAGR-52.6%

Albemarle Corp invested $51K in research and development in fiscal year 2025. This represents a decrease of 99.9% from the prior year.

Share Buybacks
N/A
Capital Expenditures
$590K
YoY-100.0%
5Y CAGR-76.7%
10Y CAGR-44.9%

Albemarle Corp invested $590K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 100.0% from the prior year.

ALB Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Revenue $1.4B+9.2% $1.3B-1.7% $1.3B+23.5% $1.1B-12.6% $1.2B-9.1% $1.4B-5.3% $1.4B+5.1% $1.4B
Cost of Revenue $1.2B+3.4% $1.2B+5.0% $1.1B+23.1% $920.6M-15.8% $1.1B-25.0% $1.5B+1.2% $1.4B+9.0% $1.3B
Gross Profit $197.9M+68.3% $117.6M-40.3% $196.9M+26.0% $156.3M+13.1% $138.2M+232.9% -$104.0M-883.5% -$10.6M-127.2% $38.9M
R&D Expenses $12.2M-3.9% $12.7M+1.8% $12.4M-11.7% $14.1M-29.6% $20.0M-10.6% $22.4M+7.8% $20.8M-11.7% $23.5M
SG&A Expenses $155.5M+12.2% $138.6M+4.6% $132.5M+7.3% $123.5M-9.2% $136.0M-11.8% $154.3M-7.3% $166.4M+3.1% $161.4M
Operating Income -$217.4M-0.2% -$217.0M-556.6% $47.5M+140.5% $19.8M+348.9% $4.4M+100.4% -$1.1B-125.1% -$492.6M-174.4% -$179.5M
Interest Expense $57.8M+13.4% $51.0M+2.0% $49.9M+2.0% $49.0M+9.6% $44.7M-6.4% $47.8M+35.7% $35.2M-7.3% $38.0M
Income Tax $157.3M+614.7% -$30.6M-189.6% $34.1M+957.1% -$4.0M-137.5% $10.6M-90.4% $110.9M+461.6% -$30.7M-724.0% -$3.7M
Net Income -$414.2M-157.7% -$160.7M-801.8% $22.9M-44.6% $41.3M-45.1% $75.3M+107.0% -$1.1B-468.0% -$188.2M-7787.8% $2.4M
EPS (Diluted) $-3.88-125.6% $-1.72-975.0% $-0.16 $0.00-100.0% $0.29+103.1% $-9.45-382.1% $-1.96-2350.0% $-0.08

ALB Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Total Assets $16.4B-4.5% $17.1B-0.8% $17.3B+1.7% $17.0B+2.3% $16.6B-4.8% $17.5B-5.1% $18.4B-3.4% $19.0B
Current Assets $4.0B-12.0% $4.6B+1.1% $4.5B+9.7% $4.1B+6.9% $3.8B-17.7% $4.7B-10.6% $5.2B-10.3% $5.8B
Cash & Equivalents $1.6B-16.2% $1.9B+6.9% $1.8B+19.0% $1.5B+27.4% $1.2B-28.4% $1.7B-9.1% $1.8B-11.0% $2.1B
Inventory $1.2B-23.1% $1.5B-6.6% $1.6B-0.9% $1.7B+10.2% $1.5B-9.4% $1.7B-7.9% $1.8B-5.5% $1.9B
Accounts Receivable $593.5M-19.1% $733.5M-4.3% $766.4M+14.3% $670.8M-9.6% $742.2M-1.0% $749.8M-4.6% $785.6M-10.1% $874.0M
Goodwill $1.5B+0.6% $1.5B-10.8% $1.7B+4.0% $1.6B+1.5% $1.6B-3.4% $1.6B+2.3% $1.6B-0.8% $1.6B
Total Liabilities $6.8B-4.4% $7.2B+1.4% $7.1B+1.2% $7.0B+4.9% $6.6B-7.9% $7.2B+0.7% $7.2B-4.5% $7.5B
Current Liabilities $1.8B-10.3% $2.0B+2.8% $1.9B+0.3% $1.9B-1.1% $2.0B+2.9% $1.9B-2.4% $2.0B-4.5% $2.1B
Long-Term Debt $3.1B-1.9% $3.2B+0.1% $3.2B+1.6% $3.1B+0.3% $3.1B-12.6% $3.6B+1.3% $3.5B0.0% $3.5B
Total Equity $9.5B-4.6% $10.0B-2.4% $10.2B+2.1% $10.0B+0.7% $10.0B-2.7% $10.2B-8.7% $11.2B-2.7% $11.5B
Retained Earnings $4.6B-9.8% $5.1B-4.7% $5.4B-1.2% $5.4B-0.9% $5.5B-0.3% $5.5B-17.4% $6.7B-4.0% $6.9B

ALB Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Operating Cash Flow $388.5M+9.2% $355.6M+4039.3% -$9.0M-101.6% $547.2M+12596.2% -$4.4M-101.9% $227.1M-38.2% $367.7M+277.1% $97.5M
Capital Expenditures $155.4M+17.6% $132.2M+10.5% $119.6M-34.5% $182.6M-46.7% $342.8M+13.1% $303.1M-32.9% $451.6M-22.6% $583.0M
Free Cash Flow $233.1M+4.3% $223.4M+273.7% -$128.7M-135.3% $364.6M+205.0% -$347.2M-356.7% -$76.0M+9.4% -$83.9M+82.7% -$485.6M
Investing Cash Flow -$176.6M-15.5% -$153.0M-148.9% $312.7M+342.3% -$129.1M+60.7% -$328.5M-3.6% -$317.1M+30.9% -$459.2M+4.3% -$480.0M
Financing Cash Flow -$533.0M-488.8% -$90.5M+0.1% -$90.6M+24.5% -$120.0M-29.2% -$92.9M+15.5% -$110.0M+2.4% -$112.7M-107.2% $1.6B
Dividends Paid $47.6M-0.1% $47.7M0.0% $47.6M+0.1% $47.6M0.0% $47.6M+1.3% $47.0M0.0% $47.0M+0.2% $46.9M
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

ALB Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Gross Margin 13.9%+4.9pp 9.0%-5.8pp 14.8%+0.3pp 14.5%+3.3pp 11.2%+18.9pp -7.7%-6.9pp -0.7%-3.6pp 2.9%
Operating Margin -15.2%+1.4pp -16.6%-20.2pp 3.6%+1.7pp 1.8%+1.5pp 0.4%+82.2pp -81.8%-47.4pp -34.4%-21.3pp -13.2%
Net Margin -29.0%-16.7pp -12.3%-14.0pp 1.7%-2.1pp 3.8%-2.3pp 6.1%+85.0pp -78.9%-65.8pp -13.2%-13.3pp 0.2%
Return on Equity N/A N/A 0.2%-0.2pp 0.4%-0.3pp 0.8% N/A N/A 0.0%
Return on Assets -2.5%-1.6pp -0.9%-1.1pp 0.1%-0.1pp 0.2%-0.2pp 0.4%+6.6pp -6.1%-5.1pp -1.0%-1.0pp 0.0%
Current Ratio 2.23-0.0 2.27-0.0 2.31+0.2 2.11+0.2 1.95-0.5 2.44-0.2 2.67-0.2 2.84
Debt-to-Equity 0.330.0 0.320.0 0.310.0 0.310.0 0.31-0.0 0.35+0.0 0.310.0 0.31
FCF Margin 16.3%-0.8pp 17.1%+26.8pp -9.7%-43.5pp 33.9%+62.1pp -28.2%-22.6pp -5.6%+0.3pp -5.9%+29.8pp -35.7%

Similar Companies

Frequently Asked Questions

What is Albemarle Corp's annual revenue?

Albemarle Corp (ALB) reported $5.1M in total revenue for fiscal year 2025. This represents a -99.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Albemarle Corp's revenue growing?

Albemarle Corp (ALB) revenue declined by 99.9% year-over-year, from $5.4B to $5.1M in fiscal year 2025.

Is Albemarle Corp profitable?

Yes, Albemarle Corp (ALB) reported a net income of $511K in fiscal year 2025, with a net profit margin of 9.9%.

What is Albemarle Corp's earnings per share (EPS)?

Albemarle Corp (ALB) reported diluted earnings per share of $5.76 for fiscal year 2025. This represents a 151.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Albemarle Corp's EBITDA?

Albemarle Corp (ALB) had EBITDA of $1.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Albemarle Corp have?

As of fiscal year 2025, Albemarle Corp (ALB) had $1.6B in cash and equivalents against $3.1M in long-term debt.

What is Albemarle Corp's gross margin?

Albemarle Corp (ALB) had a gross margin of 13.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Albemarle Corp's operating margin?

Albemarle Corp (ALB) had an operating margin of 7.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Albemarle Corp's net profit margin?

Albemarle Corp (ALB) had a net profit margin of 9.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Albemarle Corp pay dividends?

Yes, Albemarle Corp (ALB) paid $1.60 per share in dividends during fiscal year 2025.

What is Albemarle Corp's return on equity (ROE)?

Albemarle Corp (ALB) has a return on equity of 5.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Albemarle Corp's free cash flow?

Albemarle Corp (ALB) generated $692K in free cash flow during fiscal year 2025. This represents a 100.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Albemarle Corp's operating cash flow?

Albemarle Corp (ALB) generated $1.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Albemarle Corp's total assets?

Albemarle Corp (ALB) had $16.4M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Albemarle Corp's capital expenditures?

Albemarle Corp (ALB) invested $590K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Albemarle Corp spend on research and development?

Albemarle Corp (ALB) invested $51K in research and development during fiscal year 2025.

How many shares does Albemarle Corp have outstanding?

Albemarle Corp (ALB) had 118M shares outstanding as of fiscal year 2025.

What is Albemarle Corp's current ratio?

Albemarle Corp (ALB) had a current ratio of 2.23 as of fiscal year 2025, which is generally considered healthy.

What is Albemarle Corp's debt-to-equity ratio?

Albemarle Corp (ALB) had a debt-to-equity ratio of 0.33 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Albemarle Corp's return on assets (ROA)?

Albemarle Corp (ALB) had a return on assets of 3.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Albemarle Corp's Altman Z-Score?

Albemarle Corp (ALB) has an Altman Z-Score of 1720.37, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Albemarle Corp's Piotroski F-Score?

Albemarle Corp (ALB) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Albemarle Corp's earnings high quality?

Albemarle Corp (ALB) has an earnings quality ratio of 2.51x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Albemarle Corp cover its interest payments?

Albemarle Corp (ALB) has an interest coverage ratio of 333712.7x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Albemarle Corp?

Albemarle Corp (ALB) scores 49 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.